|
|
|
|
| Symbol | Name | Industry | Sector | Exchange | Cap | Cap, mln | Last | Change | Change, % | Volume |
| |
Goldman Sachs Physical Gold Etf | Exchange Traded Fund | Financial Services Etf | NYSE | Mid | 2,873.98 |
49.35 |
0.18 | 0.37 | 848,327 |
| |
Atlantic American Corp | Insurance - Life | Financial Services | NASDAQ | Micro | 52.22 |
3.05 |
0.13 | 4.45 | 11,948 |
| |
Ascentage Pharma Group International ADR | Biotechnology | Healthcare | NASDAQ | Mid | 2,228.37 |
25.00 |
0.31 | 1.26 | 169 |
| |
Innovator Equity Defined Protection Etf - 2 Yr to April 2026 | Exchange Traded Fund | Financial Services Etf | NYSE | Micro | 56.39 |
28.60 |
0 | 0 | 561 |
| |
Alpha Architect Global Factor Equity Etf | Exchange Traded Fund | Financial Services Etf | NASDAQ | Micro | 20.71 |
33.38 |
0.04 | 0.12 | 621 |
| |
iShares MSCI All Country Asia ex Japan Etf | Exchange Traded Fund | Financial Services Etf | NASDAQ | Mid | 3,590.5 |
103.76 |
-0.14 | -0.13 | 337,505 |
| |
Absolute Select Value Etf | Exchange Traded Fund | Financial Services Etf | NYSE | Micro | 128.23 |
39.10 |
0.09 | 0.23 | 10,033 |
| |
VictoryShares Pioneer Asset-Based Inc Etf | Exchange Traded Fund | Financial Services Etf | NASDAQ | Small | 293.32 |
25.00 |
-0.02 | -0.08 | 11 |
| |
Abbott Laboratories | Medical Devices | Healthcare | NYSE | Large | 196,472 |
112.27 |
-1.02 | -0.9 | 2,146,679 |
| |
Abivax S.A. ADR | Biotechnology | Healthcare | NASDAQ | Mid | 9,933.89 |
128.82 |
1.84 | 1.45 | 545,022 |
|
Please sign up to view the complete list of stocks. |
|
|
 Williams' %R - Technical Analysis from A to Z
Williams' %R is a momentum indicator that measures overbought/oversold levels. Williams' %R was developed by Larry Williams. As with all overbought/oversold indicators, it is best to wait for the security's price to change direction before placing your trades. For example, if an overbought/oversold indicator (such as the Stochastic Oscillator or Williams' %R) is showing an overbought condition, it is wise to wait for the security's price to turn down before selling the security.
|
|
| |
